Search

Author/Creator Friedberg, Jonathan W.

1. [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice. Issue 4 (3rd April 2017)

Authors:
Wong-Sefidan, Ida; Byrtek, Michelle; Zhou, Xiaolei; Friedberg, Jonathan W.; Flowers, Christopher R.; Zelenetz, Andrew D.; Dawson, Keith L.; Reid, Erin
Journal:
Leukemia & lymphoma
Issue:
Volume 58:Issue 4(2017)
Page Start:
809
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study). (10th May 2021)

Authors:
Rummel, Mathias J.; Janssens, Ann; MacDonald, David; Keating, Mary‐Margaret; Zaucha, Jan M.; Davis, Jaclyn; Lasher, Janet; Babanrao Pisal, Chaitali; Izquierdo, Miguel; Friedberg, Jonathan W.
Journal:
British journal of haematology
Issue:
Volume 193:Number 6(2021)
Page Start:
1123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806. Issue 4 (25th January 2018)

Authors:
Persky, Daniel O.; Li, Hongli; Rimsza, Lisa M.; Barr, Paul M.; Popplewell, Leslie L.; Bane, Charles L.; Von Gehr, Ann; LeBlanc, Michael; Fisher, Richard I.; Smith, Sonali M.; Friedberg, Jonathan W.
Journal:
American journal of hematology
Issue:
Volume 93:Issue 4(2018:Apr.)
Page Start:
486
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520. Issue 10 (2nd October 2016)

Authors:
Puvvada, Soham D.; Li, Hongli; Rimsza, Lisa M.; Bernstein, Steven H.; Fisher, Richard I.; LeBlanc, Michael; Schmelz, Monika; Glinsmann-Gibson, Betty; Miller, Thomas P.; Maddox, Anne-Marie; Friedberg, Jonathan W.; Smith, Sonali M.; Persky, Daniel O.
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 10(2016:Oct.)
Page Start:
2359
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). (February 2016)

Authors:
Flinn, Ian W.; Bartlett, Nancy L.; Blum, Kristie A.; Ardeshna, Kirit M.; LaCasce, Ann S.; Flowers, Christopher R.; Shustov, Andrei R.; Thress, Kenneth S.; Mitchell, Patrick; Zheng, Fred; Skolnik, Jeffrey M.; Friedberg, Jonathan W.
Journal:
European journal of cancer
Issue:
Volume 54(2016)
Page Start:
11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). (February 2016)

Authors:
Flinn, Ian W.; Bartlett, Nancy L.; Blum, Kristie A.; Ardeshna, Kirit M.; LaCasce, Ann S.; Flowers, Christopher R.; Shustov, Andrei R.; Thress, Kenneth S.; Mitchell, Patrick; Zheng, Fred; Skolnik, Jeffrey M.; Friedberg, Jonathan W.
Journal:
European journal of cancer
Issue:
Volume 54(2016)
Page Start:
11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412. Issue 12 (20th April 2021)

Authors:
Nowakowski, Grzegorz S.; Hong, Fangxin; Scott, David W.; Macon, William R.; King, Rebecca L.; Habermann, Thomas M.; Wagner-Johnston, Nina; Casulo, Carla; Wade, James L.; Nagargoje, Gauri G.; Reynolds, C. M.; Cohen, Jonathon B.; Khan, Nadia; Amengual, Jennifer E.; Richards, Kristy L.; Little, R. F...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 12(2021)
Page Start:
1329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis. Issue 8 (3rd July 2019)

Authors:
Al-Mansour, Zeina; Li, Hongli; Cook, James R.; Constine, Louis S.; Couban, Stephen; Stewart, Douglas A.; Shea, Thomas C.; Porcu, Pierluigi; Winter, Jane N.; Kahl, Brad S.; Smith, Sonali M.; Marcellus, Deborah C.; Barton, Kevin P.; Mills, Glenn M.; LeBlanc, Michael; Rimsza, Lisa M.; Forman, Stephe...
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 8(2019)
Page Start:
1934
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗